The Nifty was well on its way to higher highs before Argentina happened. The index ended the week +0.08% (-1.25% in USD terms.)
Index Performance
IT was the only silver lining…
Top winners and losers
Ranbaxy got hit by the US-FDA ban. The price action in Godrej Consumer Products bears scrutiny…
ETFs
| JUNIORBEES | +1.51% |
| NIFTYBEES | +0.37% |
| GOLDBEES | +0.35% |
| BANKBEES | +0.20% |
| INFRABEES | -1.29% |
| PSUBNKBEES | -1.44% |
Infrastructure continued its slide and PSU banks were the worst hit…
Advancers and Decliners
Yield Curve
Higher and flatter…
Investment Theme Performance
| ADAG Mania | +3.06% |
| Velocity* | +2.32% |
| Long Term Equity* | +1.67% |
| Balance-sheet Strength | +0.76% |
| Momentum 200 | +0.49% |
| Efficient Growth | +0.13% |
| Quality to Price | -0.01% |
| Market Elephants | -0.17% |
| Magic Formula Investing | -0.26% |
| Growth with Moat | -0.32% |
| Consistent10* | -0.33% |
| Financial Strength Value | -0.81% |
| Enterprise Yield | -1.17% |
| Market Fliers | -1.48% |
Momentum themes were well on their way to stardom. But Argentina happened…
Sector Performance
Fertilizer stocks fell out of favor in a hurry…
Thought for the weekend
Customers are increasingly discovering and buying new solutions in a “bottoms-up” way. The bottoms-up buying model undermines the account control and selling motion advantages of traditional Big Tech companies. Most products, even infrastructure products, are now sold in some form of subscription. These changes in selling, pricing and customer management are hard for incumbents to embrace.
Source: Big Tech Is Going Down
Comments are closed, but trackbacks and pingbacks are open.